Posfrea
Payments companies reported to CMS as associated with Posfrea. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Posfrea, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Posfrea
These are the largest totals companies reported as associated with Posfrea. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Mohit Narang | Owing Mills, MD | Medical Oncology | $5,082.48 |
| Vikram Gorantla | Pittsburgh, PA | Hematology & Oncology | $5,000.00 |
| Salim Contractor | Hudson, NY | Medical Oncology | $1,000.00 |
| Gang Tian | Germantown, TN | Hematology & Oncology | $1,000.00 |
| Giancarlo Pillot | Bridgeton, MO | Hematology & Oncology | $1,000.00 |
| Russell Gollard | Henderson, NV | Hematology & Oncology | $1,000.00 |
| Shalin Shah | Plainfield, IL | Internal Medicine | $423.53 |
| Sandeep Chunduri | Crystal Lake, IL | Hematology & Oncology | $423.53 |
| Salman Waheed | Joliet, IL | Hematology & Oncology | $423.53 |
| Samir Desai | Plainfield, IL | Hematology & Oncology | $423.53 |
Prescribed Posfrea?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.